Claude Griscelli - bibliography

Bibliography

• C. Griscelli, P. Vassalli, R. McCluskey:
  The distribution of large dividing lymph node cells in syngeneic recipient rats after intravenous injection.
  The Journal of Experimental Medicine, New York, 1969, 130 (6): 1427-1451.
• D. Guy-Grand, C. Griscelli, P. Vassalli:
  The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions.
  The Journal of Experimental Medicine, 1978, 148 (6): 1661-1677.
• C. Griscelli, A. Durandy, J.L. Virelizier, J.J. Ballet, F. Daguillard:
  Selective defect of precursor T cells associated with apparently normal B lymphocytes in severe combined immunodeficiency disease.
  The Journal of Pediatrics, 1978, (3): 404-411.
• C. Griscelli, A. Durandy, D. Guy-Grand, F. Daguillard, C. Herzog, M. Prunieras:
  A syndrome associating partial albinism and immunodeficiency.
  The American Journal of Medicine, New York, 1978, 65 (4): 691-702.
• A. Fischer, J.J. Ballet, C. Griscelli:
  Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.
  The Journal of Clinical Investigation, Ann Arbor MI, November 1978, 62 (5): 1005-1013.
• J.L. Virelizier, C. Griscelli:
  Interferon administration as an immunoregulatory and antimicrobial treatment in children with defective interferon secretion.
  In: Seligmann, M.; Hitzig, W. H.: Primary Immunodeficiencies.
  Amsterdam: Elsevier/North Holland Biomedical Press, 1980: 473-484.
• J.L. Virelizier, A. Lagrue, A. Durandy, F. Arenzana, C. Oury, C. Griscelli, P. Reinert:
  Reversal of natural killer defect in a patient with Chediak-Higashi syndrome after bone-marrow transplantation. Letter.
  The New England Journal of Medicine, 1982, 306: 1055-1056.
• E. Vilmer, A. Fischer, C. Griscelli, F. Barre-Sinoussi, V. Vie, J.C. Chermann, L. Montagnier, C. Rouzioux, F. Brun-Vezinet, W. Rosenbaum:
  Possible transmission of a human lymphotropic retrovirus (LAV) from mother to infant with AIDS. The Lancet, 1984 2 (8396): 229-230.
• C. de Préval, B. Lisowska-Grospierre, M. Loche, C. Griscelli, B. Mach:
  A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature, 318 (6043): 291-293.
• A. Marcadet, D. Cohen, J. Dausset, A. Fischer, A. Durandy, C. Griscelli:
  Genotyping with DNA probes in combined immunodeficiency syndrome with defective expression of HLA.
  The New England Journal of Medicine, 1985, 312 (20): 1287-1292.
• A. Fischer, J.L. Virelizier, S.F. Arenzana, N. Perez, C. Nezelof, C. Griscelli:
  Treatment of four patients wth erythrophago¬cytosis by a combination of epipodophyllotoxin, steroids, intracranial methotrexate and cranial irradiation.
  Pediatrics, 1985, 76: 263-268.
• G. de Saint Basile, B. Arveiler, I. Oberlé, S. Malcolm, R.J. Levinsky, Y.L. Lau, M. Hofker, M. Debre, A. Fischer, C. Griscelli:
  Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13.
  Proceedings of the National Academy of Sciences of the United States of America, Washington, 1987, 84 (21): 7576-7590.
• M. Bejaoui, F. Veber, D. Girault, C. Gaud, S. Blanche, C. Griscelli, A. Fischer:
  Phase acceleree de la maladie de Chediak-Higashi.
  Archives francaises de pédiatrie, Paris, 1989, 46: 733-736.
• S. Markiewicz, J.P. DiSanto, J. Chelly, N. Fairweather, B. Le Marec, C. Griscelli, M.B. Graeber, U. Müller, A. Fischer, A.P. Monaco:
  Fine mapping of the human SCIDX1 locus at Xq12-13.1.
  Human Molecular Genetics, 1993, 2 (6): 651-654.
• A. Durandy, J. Breton-Gorius, D. Guy-Grand, C. Dumez, C. Griscelli:
  Prenatal diagnosis of syndrome associating albinism and immunodefiencies (Chediak Hegashi syndrome and variant).
  Prenatal Diagnosis, Chichester, Uk, 1993, 13: 13-20.
• E. Pastural, F.J. Barrat, R. Dufourcq-Lagelouse, O. Certain S, Sanal, N. Jabado, R. Seger, C. Griscelli, A. Fischer, Geneviève de Saint Basile:
  Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nature Genetics, New York, 1997, 16 (3): 289-292.